Overcoming The Unknown:
New Approaches to the Diagnosis
and Treatment of Carcinomas
of Unknown Primary

Speakers

 

Chairman

Maurice Slevin   Founding partner, The London Oncology Clinic

Keynote speaker

F. Anthony Greco  Director, The Sarah Cannon Cancer Center

 

Speakers and expert panellists

Jill Bartrop MBE   Independent Cancer Patient Voice

John Bridgewater  Senior Lecturer in Medical Oncology, UCL Cancer Institute

Dalia Cohen  Chief Scientific Officer, Rosetta Genomics  

Carol L Davis  Lead Consultant in Palliative Medicine, Southampton University Hospitals NHS Trust

Daphne de Jong  Senior Staff Pathologist, Department of Pathology, The Netherlands Cancer Institute

Mark G. Erlander  Chief Scientific Officer, bioTheranostics

Eugene Halligan  Infection Molecular Development Manager, GSTS Pathology, St. Thomas’ Hospital, London

James Mackay  Consultant Clinical Genetic Oncologist, London Oncology Clinic

Christophe Massard  Research Fellow, Royal Marsden Hospital, London (formerly assistant professor, Institut Gustave Roussy)

Karin Oien   Senior Lecturer in Molecular Pathology and Honorary Consultant Pathologist, Centre for Oncology & Applied Pharmacology Cancer Research UK Beatson Laboratories, University of Glasgow

Richard Osborne  Consultant in Medical Oncology, Dorset Cancer Centre. Lead Clinician, CUP Guideline Development Group

Gauri Varadhachary   Associate Professor of Medicine, The University of Texas MD Anderson Cancer Center

Harpreet Wasan   Consultant Medical Oncologist, Hammersmith Hospital. Chief Investigator, CUP-One Trial

 

 

 

 

 

Message board

 

The programme will start at 0930 hrs and is likely to conclude at about 1730 hrs.

  Major Sponsors